FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years
Go back to FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years| (NASDAQ: BNTX) | Delayed: 99.51 -4.25 (4.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.76 | 52 Week High | $ | |||
| Open | $100.24 | 52 Week Low | $ | |||
| Day High | $101.33 | P/E | N/A | |||
| Day Low | $98.18 | EPS | $ | |||
| Volume | 780,964 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.91 -0.54 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.02 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.92 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 18,920,485 | |||||

